跳至主要内容
临床试验/TCTR20160412001
TCTR20160412001已完成4 期

Topical Tranexamic Acid in Reducing post-operative Blood Lossin thoraco-lumbar spine injury A Prospective Randomized Controlled Trial.

none0 个研究点目标入组 56 人开始时间: 2016年4月12日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
56

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 70 Years(—)
性别
All

入选标准

  • a.Men and women, 18 to 70 years of age with injuries involving the thoracic or lumbar spine (Thoracolumbar Injury Classification and Severity score  5) undergoing long-segment (4 levels) instrumented posterior spinal fusion with local autologous bone graft
  • b.No neurological deficits
  • c.American Society of Anesthesiologists physical status class I, II or III

排除标准

  • a.Renal insufficiency
  • b.History of thromboembolic events (e.g., pulmonary embolism, embolic stroke, and deep venous thrombosis)
  • c.History of significant cardiovascular diseases (e.g., unstable angina, recent myocardial infarction, significant arrhythmia, and uncontrolled hypertension)
  • d.History of acquired defective color vision
  • e.Coagulation disorder
  • f.Gross hematuria or microhematuria
  • g.Dural tear
  • h.Allergy to tranexamic acid
  • i.Take aspirin or nonsteroidal anti-inflammatory drugs within a week before randomization and during the study period

研究者

发起方
none

相似试验